The open enrollment period for the 2026 Medicare Part D drug plans will commence in Guam on October 16 and run until December 7, according to...
On October 1, 2023, patients across the United States abruptly lost access to telemedicine services that had become vital during the COVID-19 pandemic. This change occurred...
The Trump administration is exploring a regulatory approach aimed at compelling drug manufacturers to reduce prices in the United States to levels that align with those...
Australia is taking a significant step towards healthcare inclusivity as an independent committee examines the possibility of Medicare funding for gender-affirming surgeries for transgender adults, specifically...
A federal judge has ordered CVS Health’s pharmacy benefit manager, Caremark, to pay nearly $290 million following allegations of fraud against Medicare related to prescription drug...
Consumers navigating the complexities of Medicare Part D often face significant challenges, particularly regarding prescription drug coverage. Joel Mekler highlights the dual categories of issues that...
